Charles Rudin

Charles M. Rudin, MD, PhD

Areas of Expertise

Conditions I Treat

  • Lung cancer
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I am a board-certified medical oncologist specializing in the care of patients with lung cancer.

I am the Deputy Director of the Cancer Center at MSK. I also co-direct the Druckenmiller Center focused on pre-clinical lung cancer research at MSK. I serve on the National Cancer Institute Board of Scientific Advisors, and have led the National Cancer Institute’s Small Cell Lung Cancer Research Consortium since its inception in 2015.

Read more

I direct a broad research program of therapeutic research with the ultimate goal of improving the outcome for patients with lung cancer. My research includes laboratory-based investigations to identify and test novel treatment approaches to lung cancer, early-phase clinical trials to bring these ideas to the clinic, and later-phase studies to establish the efficacy of these new approaches.

What I Do at MSK

I'm a thoracic medical oncologist, which is a cancer doctor who specializes in thoracic (thor-A-sik) cancers. These are cancers that have to do with the chest, including lung, tracheal (windpipe), and thymic (thymus) cancers.

  • Cancer Center Deputy Director
  • Co-Director, Druckenmiller Center for Lung Cancer Research
  • Sylvia Hassenfeld Chair in Lung Cancer Research
Areas of Expertise

Conditions I Treat

  • Lung cancer
Education & Honors

Education

  • MD, PhD, University of Chicago Pritzker School of Medicine

Residencies

  • University of Chicago Medical Center

Fellowships

  • University of Chicago Medical Center

Board Certifications

  • Medical Oncology

Awards and Honors

  • Castle Connolly: America’s Top Doctor (2025)
  • Castle Connolly: America’s Top Doctor (2024)
  • Top Doctors New York Metro Area, Castle Connolly (2023)
  • Castle Connolly: America's Top Doctors (2023)
  • Outstanding Investigator Award, National Cancer Institute
  • Director's Service Award, National Cancer Institute
  • Paul Bunn Lifetime Achievement Award, International Association for the Study of Lung Cancer
  • Association of American Physicians

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Current Patients
Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Dr. Rudin sees patients at one location.

Office Phone
Location
New York, NY

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Thoracic Oncology Service doctors

Clinical Trials

Read more
Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

View Dr. Rudin's Lab

Publications on PubMed

Visit PubMed for a full listing of Dr. Rudin’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Charles M. Rudin discloses the following relationships and financial interests:

  • AbbVie
    Professional Services and Activities
  • Amgen
    Professional Services and Activities
  • Boehringer Ingelheim
    Professional Services and Activities
  • D2G Oncology
    Professional Services and Activities
  • Daiichi Sankyo
    Intellectual Property Rights
  • Earli Inc.
    Equity
  • Harpoon Therapeutics, Inc.
    Professional Services and Activities
  • Jazz Pharmaceuticals
    Professional Services and Activities
  • Mariana Oncology, Inc.
    Professional Services and Activities
  • Scorpion Therapeutics, Inc.
    Professional Services and Activities
  • Treeline Biosciences, Inc.
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures